STRS Ohio’s Protara Therapeutics TARA Stock Holding History

STRS Ohio’s Portfolio TARA Stock Details TARA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-500	Closed	-$7K	–	2423
2021 Q1	$7K	Hold	500	–	–	﹤0.01%	2141
2020 Q4	$12K	Hold	500	–	–	﹤0.01%	2100
2020 Q3	$8K	Hold	500	–	–	﹤0.01%	2142
2020 Q2	$14K	Buy	+500	New	+$15.5K	﹤0.01%	2075
2016 Q2	–	Sell	-93	Closed	-$28K	–	2005
2016 Q1	$28K	Hold	93	–	–	﹤0.01%	1810
2015 Q4	$57K	Buy	93 +30	+48%	+$17.6K	﹤0.01%	1775
2015 Q3	$34K	Hold	63	–	–	﹤0.01%	1793
2015 Q2	$44K	Buy	+63	New	+$39K	﹤0.01%	1770

Other funds holding TARA

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

STRS Ohio's TARA Position: Q2 2021 in Review

STRS Ohio sold out of Protara Therapeutics (TARA) in Q2 2021, closing a stake of 500 shares — an estimated $7K sold.

STRS Ohio first reported a position in TARA in Q2 2015 and held it in 8 quarters. The position peaked at $57K in Q4 2015. 41 funds tracked by Wall St. Rank hold TARA as of Q2 2021.

STRS Ohio reported no remaining Protara Therapeutics position as of Q2 2021 after selling out during the quarter.
STRS Ohio sold 500 Protara Therapeutics shares in Q2 2021, an estimated $7K.
STRS Ohio first reported a position in Protara Therapeutics in Q2 2015 and held it in 8 quarters.
STRS Ohio's Protara Therapeutics position peaked at $57K in Q4 2015.
41 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2021.

Based on STRS Ohio's 13F filing for Q2 2021, filed 26 Jul 2021.